Assessment of pharmacokinetic drug-drug interaction between pradigastat and acetaminophen in healthy subjects

被引:0
|
作者
Surya Ayalasomayajula
Dan Meyers
Phillip Koo
Atish Salunke
Tapan Majumdar
Sam Rebello
Gangadhar Sunkara
Jin Chen
机构
[1] Novartis Institutes for BioMedical Research,
[2] Novartis Institutes for BioMedical Research,undefined
[3] Novartis Healthcare Pvt. Ltd,undefined
来源
European Journal of Clinical Pharmacology | 2015年 / 71卷
关键词
Pharmacokinetics; Drug-drug interaction; Pradigastat; Acetaminophen; Gastric motility;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:425 / 432
页数:7
相关论文
共 50 条
  • [21] Clinical Assessment of the Drug-Drug Interaction Potential of Omaveloxolone in Healthy Adult Participants
    Zahir, Hamim
    Murai, Masako
    Wu, Lucy
    Valentine, Michelle
    Hynes, Scott
    JOURNAL OF CLINICAL PHARMACOLOGY, 2025,
  • [22] Pharmacokinetic Drug-Drug Interaction and Responsible Mechanism between Memantine and Cimetidine
    Choi, Young A.
    Song, Im-Sook
    Choi, Min-Koo
    PHARMACEUTICS, 2018, 10 (03):
  • [23] Drug-drug interaction between cannabidiol and phenobarbital in healthy dogs
    Doran, Caitlin E.
    McGrath, Stephanie
    Banner, Lisa R.
    Thomas, Breonna
    Cribb, Alastair E.
    Gustafson, Daniel L.
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2022, 83 (01) : 86 - 94
  • [24] Absence of pharmacokinetic drug-drug interaction of pertuzumab with trastuzumab and docetaxel
    Cortes, Javier
    Swain, Sandra M.
    Kudaba, Iveta
    Hauschild, Maik
    Patel, Taral
    Grincuka, Elza
    Masuda, Norikazu
    McNally, Virginia
    Ross, Graham
    Brewster, Mike
    Marier, Jean-Francois
    My My Trinh
    Garg, Amit
    Nijem, Ihsan
    Visich, Jennifer
    Lum, Bert L.
    Baselga, Jose
    ANTI-CANCER DRUGS, 2013, 24 (10) : 1084 - 1092
  • [25] Evaluation of Drug-Drug Interaction Between Henagliflozin and Hydrochlorothiazide in Healthy Chinese Volunteers
    Chen, Qian
    Yu, Chengyin
    Wu, Qingqing
    Song, Rong
    Liu, Ye
    Feng, Sheng
    Yu, Chen
    Jia, Jingying
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 1855 - 1864
  • [26] Drug-Drug Interaction of Letermovir and Atorvastatin in Healthy Participants
    McCrea, Jacqueline B.
    Menzel, Karsten
    Adedoyin, Adedayo
    Cho, Carolyn R.
    Fox-Bosetti, Sabrina
    Macha, Sreeraj
    Zhao, Tian
    Liu, Fang
    Panebianco, Deborah
    Stoch, S. Aubrey
    Iwamoto, Marian
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (04): : 420 - 428
  • [27] Pharmacokinetics and drug-drug interaction between enalapril, enalaprilat and felodipine extended release (ER) in healthy subjects
    Li, Dai
    Xu, Sumei
    Wang, Yulu
    Li, Dan
    Li, Xiaomin
    Pan, Jing
    Xu, Pingsheng
    ONCOTARGET, 2017, 8 (41) : 70752 - 70760
  • [28] A Drug-drug Interaction Between Cyclosporine and Nystatin
    Liu, Wei
    Guan, Xin
    Yu, Zhiheng
    Chen, Ken
    Benet, Leslie
    Zhai, Suodi
    CLINICAL THERAPEUTICS, 2018, 40 (04) : 660 - 662
  • [29] Evaluation of the pharmacokinetic drug-drug interaction between the antiretroviral agents fostemsavir and maraviroc: a single-sequence crossover study in healthy participants
    Wire, Mary Beth
    Magee, Mindy
    Ackerman, Peter
    Llamoso, Cyril
    Moore, Katy
    HIV RESEARCH & CLINICAL PRACTICE, 2021, 23 (01) : 1 - 8
  • [30] A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers
    Kang, Woo Youl
    Lee, Hae Won
    Gwon, Mi-Ri
    Cho, Seungil
    Shim, Wang-Seob
    Lee, Kyung-Tae
    Yang, Dong Heon
    Seong, Sook Jin
    Yoon, Young-Ran
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 2101 - 2111